Data to advance the diagnosis, treatment and management of MH to be presented

Travel Award Available to share data with Clinicians and Scientists to advance the diagnosis, treatment, and management of Malignant Hyperthermia-Susceptible Patients April 23-24, 2010 at Mercy Hospital University of Pittsburgh Medical Center.

There is no charge for medical and graduate students, or residents to attend the MHAUS Sponsored Scientific Conference: "Malignant Hyperthermia: New Insights and Connections with Other Myopathies."

Session Topics and Speakers are: "Pathophysiology of MH - Overview and Recent Advances in Understanding" presented by Chair: Jerome Parness, MD, PhD, UPMC; "Genetics of MH: Results and Future Directions" presented by Chair: Sheila Muldoon, MD, Uniformed Services University of the Health Sciences (USUHS); "MH Epidemiology and Case Studies & Future Directions/ Challenges" presented by Chair: Henry Rosenberg, MD, CPE, Saint, Barnabas Medical Center.

Full meeting agenda is available and MHAUS anticipates receiving 14 or more CME credits for this program.

Poster Presentations - Deadline for submission is March 15, 2010; see website for details.

Submission of abstracts for poster presentation by researchers and clinicians with an active interest in MH and related disorders is encouraged. A travel award to support the cost of conference attendance will be offered to the investigator who submits the highest quality abstract.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Collaborative project seeks to close diagnostic gap in asthma care